Real-world outcomes of managing autosomal-dominant polycystic kidney disease using a medical food as part of a nutrition and lifestyle program to improve renal and metabolic health

Read full text
Authors: Emily Grace Muensterman, Jacob A. Torres, Thomas Weimbs
Cited by: 4
References: 30

Abstract

Background: Autosomal-dominant polycystic kidney disease (ADPKD) is a common hereditary form of chronic kidney disease with limited pharmacological treatment options. Emerging evidence suggests that metabolic interventions, including ketogenic dietary strategies and reducing lithogenic risk, may positively influence disease progression. Objectives: This study evaluated real-world outcomes from the Ren-Nu™ program, a remotely administered educational program for individuals with ADPKD that combines the use of a medical food with nutrition and lifestyle changes, including a very-low-carbohydrate ketogenic diet and reduction of renal lithogenic stressors. Ren-Nu™ was launched in 2021 as a collaboration between scientists and nutrition experts from the University of California Santa Barbara and Santa Barbara Nutrients, Inc, and dietitians from Kidney Nutrition Institute. Methods: , a medical food providing beta-hydroxybutyrate (BHB), citrate, minerals, and alkali base. Primary outcomes included estimated glomerular filtration rate (eGFR), body mass index (BMI), anti-hypertensive medication usage, and self-reported symptom burden. Safety was assessed through routine metabolic biomarkers. Results: Participants demonstrated high adherence to nutritional ketosis, leading to a significant improvement in BMI. Renal function significantly improved, showing an eGFR increase of 6.3% (from 58.4 to 61.6 ml/min/1.73 m2; P < 0.001). There was a notable decrease in anti-hypertensive medication use and significant reductions in self-reported kidney pain and headaches. Safety markers, including lipid profiles, electrolytes, and acid-base balance, remained stable throughout the intervention. Conclusion: supported by nutrition and lifestyle changes in the Ren-Nu™ program demonstrates feasibility, safety, and clinically meaningful improvements in metabolic health, renal function, and quality.

Fields of Study & Subjects

Genetic and Kidney Cyst Diseases Diet and metabolism studies Biomedical Research and Pathophysiology

Publication details

Journal / source
Frontiers in Nutrition
Publisher
Frontiers Media SA
Volume
12
Pages
1624639–1624639
Publication date
21 January 2026
Language
EN